Knowledge Gate Group ApS
Key figures
- Return on assets
- -84.7%
- Return on equity
- –
- Current ratio
- 22.6%
- Equity ratio
- -403.8%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | 4,164,597 |
Operating profit | -2,987,465 |
Finance income | 644 |
Profit/loss for the year | -3,721,347 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 7 |
Personnel costs | 6,771,920 DKK |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 294,855 |
Current assets | 2,158,779 |
Non-current assets | 1,370,327 |
Total assets | 3,529,106 |
Equity | -14,249,597 |
Liabilities | 17,778,703 |
Current liabilities | 9,549,705 |
Working capital
| Reporting period | |
|---|---|
Trade receivables | 1,839,958 |
Other current receivables | 0 |
Trade payables | 115,370 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 45,789 |
Retained earnings | -15,251,610 |
Investments and assets
| Reporting period | |
|---|---|
Long-term investments and receivables | 144,400 |
Property, plant and equipment | 0 |
Annual report highlights
Business and development
The company's activity consists of running a business that connects life science companies with experts via a proprietary platform for advisory services (micro-consultations). Included within this is the development and sale of access to the associated software in relation to knowledge sharing.
Development in activities and finances
The year's result shows a deficit of DKK 3,721,735. The management considered the result to be unsatisfactory, but as expected as a result of the company's growth journey. The company's equity is lost. Management is aware of the capital loss rules in Section 119 of the Companies Act. During 2024/25 the company spent significant resources on further developing their market position for local Danish as well as foreign markets. In 2024/25, the company has proven itself in establishing itself as a competitive provider in the market of providing life science companies access to experts worldwide and has had an inceasing activity. During 2025/26 the management has succeeded in raising capital for expenses. This has been done via loans from externa…
Risks and material matters
The year's result shows a deficit of DKK 3,721,735. The management considered the result to be unsatisfactory, but as expected as a result of the company's growth journey. The company's equity is lost. Management is aware of the capital loss rules in Section 119 of the Companies Act. During 2024/25 the company spent significant resources on further developing their market position for local Danish as well as foreign markets. In 2024/25, the company has proven itself in establishing itself as a competitive provider in the market of providing life science companies access to experts worldwide and has had an inceasing activity. During 2025/26 the management has succeeded in raising capital for expenses. This has been done via loans from external lenders. The management expects a lo…
No events have occurred after the balance sheet date to this date, which would influence the evaluation of this annual report.
Commitments and security
The Entity participates in a Danish joint taxation arrangement where Athena Holding ApSserves as the administration company. According to the joint taxation provisions of the Danish Corporation Tax Act, the Entity istherefore liable for income taxes etc for the jointly taxed entities, and for obligations, if any, relating to the withholding of tax on interest, royalties and dividend for the jointly taxed entities.
13 Assets charged and collateral
A company mortgage with a principal of DKK 1,500,000. is provided as security for Vækstfonden (EIFO). The corporate pledge includes intangible assets, receivables from sales and services and property, plant and equipment at a total value of DKK 3,867,484.
Create a free account to see up to 9 years of financial history
Create free account